Building on more than a decade of research in medical physics, radiation biology, and oncology and founded by Prof. Dr Stefan Bartzsch, Dr Johanna Winter, and Dr Hans Maria Heÿn, the company is working to make advanced forms of radiation therapy accessible within standard clinical settings while improving outcomes for patients with some of the most challenging cancers.
The company's vision is to expand the therapeutic potential of radiotherapy by increasing treatment precision while reducing damage to healthy tissue. By combining breakthrough hardware innovation with integrated treatment planning and deep expertise in radiation biology, Collimate Health is developing a platform designed to support the next wave of advances in cancer care.
XISTA Team
Image
